Equities

Globus Medical Inc

Globus Medical Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)51.20
  • Today's Change-0.590 / -1.14%
  • Shares traded1.16m
  • 1 Year change-13.26%
  • Beta1.0998
Data delayed at least 15 minutes, as of Apr 17 2024 21:10 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Globus Medical, Inc. is a medical device company that develops and commercializes healthcare solutions with a focus on improving the quality of life of patients with musculoskeletal disorders. The Company offers a portfolio of differentiated technologies that are used to treat a variety of musculoskeletal conditions. Musculoskeletal Solutions consist primarily of implantable devices, biologics, accessories, and surgical instruments used in a range of spinal, orthopedic and neurosurgical procedures. Its spine products address the majority of conditions affecting the spine, including degenerative conditions, deformity, tumors, and trauma. It provides solutions that facilitate both open and minimally invasive surgery (MIS) techniques. It includes traditional fusion implants, such as pedicle screws and rod systems. Its orthopedic trauma solutions are designed to treat a variety of orthopedic fracture patterns and patient anatomies in the upper and lower extremities, as well as the hip.

  • Revenue in USD (TTM)1.57bn
  • Net income in USD122.87m
  • Incorporated2003
  • Employees5.00k
  • Location
    Globus Medical Inc2560 General Armistead AveAUDUBON 19403-5214United StatesUSA
  • Phone+1 (610) 930-1800
  • Fax+1 (302) 636-5454
  • Websitehttps://www.globusmedical.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Integer Holdings Corp1.60bn90.65m4.00bn10.50k44.472.6221.102.502.682.6847.3045.580.55665.255.15152,064.103.163.283.433.5326.3026.945.686.401.713.540.38980.0016.035.6238.719.3321.71--
Merit Medical Systems Inc1.26bn94.41m4.22bn6.95k44.973.5022.913.361.621.6221.5520.780.63042.367.34180,916.004.732.455.302.7746.4444.507.513.913.959.890.40640.009.247.3326.7015.86-11.16--
Lantheus Holdings Inc1.30bn326.66m4.23bn834.0013.305.1810.943.264.644.6418.5911.910.87239.465.211,554,471.0021.986.6925.757.7363.7153.9025.209.025.451,235.430.40810.0038.6530.441,063.8651.8135.48--
Haemonetics Corporation1.27bn126.57m4.27bn3.03k34.064.5319.433.372.472.4724.8018.570.62292.116.47418,649.006.214.747.055.8953.4849.779.977.411.7625.450.480.0017.675.27166.059.488.06--
Glaukos Corp314.71m-134.66m4.80bn907.00--10.31--15.24-2.78-2.786.509.400.3241.898.29346,980.20-13.86-8.73-14.99-9.3575.9974.77-42.79-28.694.78-27.680.4335--11.2611.66-35.75--14.44--
Novanta Inc881.66m72.88m5.70bn2.90k78.508.4447.696.462.022.0224.4718.800.71473.046.36304,021.405.915.466.746.3445.3643.248.277.711.914.830.34770.002.417.49-1.588.214.19--
DENTSPLY SIRONA Inc3.97bn-132.00m6.39bn15.00k--1.9430.301.61-0.6217-0.621718.6715.890.52823.005.98264,333.30-1.76-1.14-2.13-1.3252.7153.65-3.33-2.510.94673.630.3914--1.10-0.107186.11---4.549.86
Inspire Medical Systems Inc624.80m-21.15m6.71bn1.01k--11.44--10.75-0.7298-0.729821.3219.371.014.228.27618,001.00-3.41-11.27-3.84-12.6084.5484.47-3.39-13.577.17--0.00--53.1965.3252.87--148.37--
Globus Medical Inc1.57bn122.87m7.01bn5.00k44.441.7726.114.471.171.1713.7229.320.4380.95574.38313,695.203.436.903.727.4565.0571.737.8314.052.72--0.09470.0053.3417.08-35.39-4.725.57--
Masimo Corp2.05bn81.50m7.31bn3.80k91.705.3540.693.571.511.5137.8425.850.65522.005.04538,973.702.618.653.2210.3149.0057.303.9812.031.223.430.3990.000.604219.00-43.21-15.9631.06--
MSA Safety Inc1.79bn58.52m7.35bn5.10k130.577.6361.624.111.431.4345.2124.590.78632.976.04350,518.802.585.083.036.0047.6745.213.287.021.486.070.383665.9117.005.65-67.41-13.664.72-1.10
Penumbra Inc1.06bn90.95m8.13bn4.20k90.676.8968.777.682.322.3227.0030.480.72321.045.23252,029.006.212.326.912.6164.4963.908.593.173.49--0.02150.0024.9518.934,643.1668.609.64--
Stevanato Group SpA1.15bn154.62m8.75bn5.64k49.686.3836.747.590.58320.58324.344.540.58183.142.75204,492.507.81--10.81--32.28--13.42--1.0619.740.2593--10.34--1.95------
Henry Schein, Inc.12.34bn416.00m9.15bn25.00k22.602.5213.660.74163.153.1593.6728.281.294.497.47493,560.004.406.097.3110.4431.2930.043.424.400.996310.630.31330.00-2.445.55-22.68-0.145621.27--
Teleflex Inc2.97bn357.57m9.90bn14.50k27.802.2316.503.337.567.5362.8894.410.41142.206.98205,137.204.955.865.396.4255.3755.0412.0214.621.297.780.290115.846.573.97-1.4712.732.510.00
Data as of Apr 17 2024. Currency figures normalised to Globus Medical Inc's reporting currency: US Dollar USD

Institutional shareholders

40.69%Per cent of shares held by top holders
HolderShares% Held
The Vanguard Group, Inc.as of 31 Dec 202311.11m9.84%
BlackRock Fund Advisorsas of 31 Dec 202310.02m8.87%
Janus Henderson Investors US LLCas of 31 Dec 20237.85m6.95%
SSgA Funds Management, Inc.as of 31 Dec 20233.54m3.13%
Wellington Management Co. LLPas of 31 Dec 20232.91m2.58%
William Blair Investment Management LLCas of 31 Dec 20232.31m2.04%
Camber Capital Management LPas of 31 Dec 20232.25m1.99%
Millennium Management LLCas of 31 Dec 20232.02m1.79%
Champlain Investment Partners LLCas of 31 Dec 20232.00m1.77%
Geode Capital Management LLCas of 31 Dec 20231.95m1.72%
More ▼
Data from 31 Dec 2023 - 31 Dec 2023Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.